Tehran-SANA
The chief researcher working on the production of the Iranian Corona vaccine (Razi Cove Pars), Saeed Kalantari, announced the success of the first part of the first phase of the human test for this vaccine.
"We have started the first phase of human testing for the vaccine (Razi Cove Pars)," said Clantree, in a statement today, explaining that a week ago, 13 volunteers were vaccinated and had no unusual symptoms and reactions, which confirms the success of the research work in terms of symptoms.
He added that the second part of the first phase will vaccinate 120 volunteers between the ages of 18 and 55, who will be divided into 4 groups of 30 people each, explaining that the goal of this phase is to ensure that the vaccine is safe and without risk.
